Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Summary Keywords IBD, GLP-1, GLP-1 receptor agonists, diabetes, obesity Citation Migliorisi G, Gabbiadini R, Dal Buono A, Ferraris M, Privitera G, Petronio L, Bertoli P, Bezzio C and Armuzzi A (2025) GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation
Their use is rising rapidly, and with good reason: These medications have been shown to reduce blood sugar, improve fatty liver, GERD, sleep apnea, osteoarthritis, blood pressure, triglycerides, major adverse cardiovascular events, and even show potential benefits for conditions like alcohol use disorder (Mozaffarian et al., 2025
Methods Using a subset of Truveta Data, we found a population of adolescent patients (aged 12-17 years old) who had a recorded body mass index (BMI) on the same day as an outpatient visit between January 1, 2021 and March 31, 2025
[37] observed that after internalization, GLP-1R/ligand complex could be co-localized with adenylate cyclase in the endosome
The healthy eating habits, regular exercise, and self-care routines youre building are not just to lose weight theyre to keep you healthier for life
January 10, 2023
